Effectiveness of conservative interventions including exercise, manual therapy and medical management in adults with shoulder impingement: a systematic review and meta-analysis of RCTs
To investigate the effectiveness of conservative interventions for pain, function and range of motion in adults with shoulder impingement.
Systematic review and meta-analysis of randomised trials.
Medline, CENTRAL, CINAHL, Embase and PEDro were searched from inception to January 2017.
Randomised controlled trials including participants with shoulder impingement and evaluating at least one conservative intervention against sham or other treatments.
For pain, exercise was superior to non-exercise control interventions (standardised mean difference (SMD) –0.94, 95% CI –1.69 to –0.19). Specific exercises were superior to generic exercises (SMD –0.65, 95% CI –0.99 to –0.32). Corticosteroid injections were superior to no treatment (SMD –0.65, 95% CI –1.04 to –0.26), and ultrasound guided injections were superior to non-guided injections (SMD –0.51, 95% CI –0.89 to –0.13). Nonsteroidal anti-inflammatory drugs (NSAIDS) had a small to moderate SMD of –0.29 (95% CI –0.53 to –0.05) compared with placebo. Manual therapy was superior to placebo (SMD –0.35, 95% CI –0.69 to –0.01). When combined with exercise, manual therapy was superior to exercise alone, but only at the shortest follow-up (SMD –0.32, 95% CI –0.62 to –0.01). Laser was superior to sham laser (SMD –0.88, 95% CI –1.48 to –0.27). Extracorporeal shockwave therapy (ECSWT) was superior to sham (–0.39, 95% CI –0.78 to –0.01) and tape was superior to sham (–0.64, 95% CI –1.16 to –0.12), with small to moderate SMDs.
Although there was only very low quality evidence, exercise should be considered for patients with shoulder impingement symptoms and tape, ECSWT, laser or manual therapy might be added. NSAIDS and corticosteroids are superior to placebo, but it is unclear how these treatments compare to exercise.
Publisher URL: http://bjsm.bmj.com/cgi/content/short/51/18/1340
Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.
Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.